Low-toxicity, long-circulating chimeras of human interferonalpha analogs and interferon tau

Details for Australian Patent Application No. 2006262151 (hide)

Owner Pepgen Corporation

Inventors Liu, Chih-Ping; Villarete, Lorelie H.

Agent FB Rice

Pub. Number AU-A-2006262151

PCT Pub. Number WO2007/002233

Priority 60/692,484 20.06.05 US

Filing date 20 June 2006

Wipo publication date 4 January 2007

International Classifications

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07K 14/56 (2006.01) Peptides having more than 20 amino acids

Event Publications

31 January 2008 PCT application entered the National Phase

  PCT publication WO2007/002233 Priority application(s): WO2007/002233

20 May 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006262152-Package design for producing white light with short-wavelength leds and down-conversion materials

2006262150-PRRS viruses, infectious clones, mutants thereof, and methods of use